title: A detailed physiologically based model to simulate the pharmacokinetics and hormonal pharmacodynamics of enalapril on the circulating endocrine Renin-Angiotensin-aldosterone system.
abstract: The renin-angiotensin-aldosterone system (RAAS) plays a key role in the pathogenesis of cardiovascular disorders including hypertension and is one of the most important targets for drugs. A whole body physiologically based pharmacokinetic (wb PBPK) model integrating this hormone circulation system and its inhibition can be used to explore the influence of drugs that interfere with this system, and thus to improve the understanding of interactions between drugs and the target system. In this study, we describe the development of a mechanistic RAAS model and exemplify drug action by a simulation of enalapril administration. Enalapril and its metabolite enalaprilat are potent inhibitors of the angiotensin-converting-enzyme (ACE). To this end, a coupled dynamic parent-metabolite PBPK model was developed and linked with the RAAS model that consists of seven coupled PBPK models for aldosterone, ACE, angiotensin 1, angiotensin 2, angiotensin 2 receptor type 1, renin, and prorenin. The results indicate that the model represents the interactions in the RAAS in response to the pharmacokinetics (PK) and pharmacodynamics (PD) of enalapril and enalaprilat in an accurate manner. The full set of RAAS-hormone profiles and interactions are consistently described at pre- and post-administration steady state as well as during their dynamic transition and show a good agreement with literature data. The model allows a simultaneous representation of the parent-metabolite conversion to the active form as well as the effect of the drug on the hormone levels, offering a detailed mechanistic insight into the hormone cascade and its inhibition. This model constitutes a first major step to establish a PBPK-PD-model including the PK and the mode of action (MoA) of a drug acting on a dynamic RAAS that can be further used to link to clinical endpoints such as blood pressure.
authors: School of Engineering and Science, Jacobs University Bremen Bremen, Germany ; Computational Systems Biology, Bayer Technology Services GmbH Leverkusen, Germany.
authors: Karina
authors: K
authors: Claassen
authors: Stefan
authors: S
authors: Willmann
authors: Thomas
authors: T
authors: Eissing
authors: Tobias
authors: T
authors: Preusser
authors: Michael
authors: M
authors: Block
keywords: cardiovascular; enalapril; enalaprilat; physiologically based pharmacokinetic model; renin-angiotensin-aldosterone system
references: Br J Clin Pharmacol. 1984;18 Suppl 2:233S-239S, 241S
references: 6099738
references: Chest. 1995 Mar;107(3):706-10
references: 7874941
references: Expert Opin Drug Metab Toxicol. 2008 Sep;4(9):1143-52
references: 18721109
references: Front Biosci. 2008 May 01;13:3931-9
references: 18508487
references: J Hum Hypertens. 1995 Jun;9(6):385-90
references: 7473515
references: Front Physiol. 2011 Feb 24;2:4
references: 21483730
references: Am J Physiol Renal Physiol. 2007 Sep;293(3):F956-60
references: 17553939
references: J Cardiovasc Pharmacol. 1984 May-Jun;6(3):436-41
references: 6202969
references: Endocr Rev. 2008 Dec;29(7):823-64
references: 18940916
references: Nucleic Acids Res. 2011 Jan;39(Database issue):D1035-41
references: 21059682
references: Hypertension. 1997 Feb;29(2):634-40
references: 9040450
references: Biochem Med. 1980 Dec;24(3):321-6
references: 7025836
references: Clin Pharmacokinet. 2006;45(10):1013-34
references: 16984214
references: Clin Pharmacokinet. 2006;45(7):683-704
references: 16802850
references: Pharm Res. 2003 Nov;20(11):1766-71
references: 14661920
references: Nucleic Acids Res. 2012 Jan;40(Database issue):D400-12
references: 22140110
references: Exp Physiol. 2009 Apr;94(4):389-96
references: 19286640
references: Can J Physiol Pharmacol. 1999 Mar;77(3):216-23
references: 10535696
references: J Biomed Eng. 1989 Jan;11(1):63-71
references: 2648070
references: Br J Clin Pharmacol. 1982 Sep;14(3):363-8
references: 6289859
references: Adv Ther. 2006 Jan-Feb;23(1):143-58
references: 16644615
references: Circulation. 2012 Jan 3;125(1):e2-e220
references: 22179539
references: Acta Biotheor. 2010 Sep;58(2-3):143-70
references: 20683640
references: Hypertension. 1990 Nov;16(5):564-72
references: 2172161
references: J Med Chem. 2004 Jul 29;47(16):4022-31
references: 15267240
references: Am J Cardiol. 2001 Nov 8;88(9A):1L-20L
references: 11694220
references: Am J Hypertens. 2012 Sep;25(9):1030-4
references: 22695510
references: Drug Metab Dispos. 2000 Jul;28(7):807-13
references: 10859155
references: J Pharmacokinet Pharmacodyn. 2007 Jun;34(3):401-31
references: 17431751
references: Annu Rev Physiol. 1972;34:13-46
references: 4334846
references: Pharm Res. 1992 Nov;9(11):1480-6
references: 1475237
references: Rapid Commun Mass Spectrom. 2003;17(11):1157-62
references: 12772271
references: Arzneimittelforschung. 1990 Aug;40(8):865-7
references: 2173610
references: Am J Physiol. 1990 Dec;259(6 Pt 2):F882-7
references: 2260680
references: Exp Physiol. 2009 Apr;94(4):382-8
references: 19286638
references: J Pharmacol Exp Ther. 1990 Apr;253(1):362-8
references: 2158548
references: Hypertension. 2002 Jan;39(1):E1-8
references: 11799102
references: J Pharm Biomed Anal. 2009 Jan 15;49(1):163-7
references: 19046843
references: Vasc Health Risk Manag. 2010 Aug 09;6:549-59
references: 20730071
references: Biopharm Drug Dispos. 2003 Oct;24(7):315-20
references: 14520685
references: Nucleic Acids Res. 2009 Jan;37(Database issue):D603-10
references: 18953024
references: Nucleic Acids Res. 2012 Jan;40(Database issue):D71-5
references: 22102590
references: Lancet. 1967 Nov 11;2(7524):1002-5
references: 4168520
references: Clin Pharmacokinet. 1993 Oct;25(4):274-82
references: 8261712
references: Drug Metab Dispos. 1998 Apr;26(4):324-31
references: 9531519
references: BMC Clin Pharmacol. 2006 Jan 06;6:1
references: 16398929
references: Biochem Pharmacol. 1984 Apr 15;33(8):1273-6
references: 6324821
references: J Chromatogr B Analyt Technol Biomed Life Sci. 2004 Dec 25;813(1-2):337-42
references: 15556550
references: Br J Clin Pharmacol. 1986 Apr;21(4):341-8
references: 3011046
references: Pharmacol Res. 2012 Aug;66(2):177-84
references: 22513176
references: Biochemistry. 1988 Jul 26;27(15):5538-44
references: 2846041
references: Drug Metab Dispos. 2012 May;40(5):892-901
references: 22293118
references: Basic Clin Pharmacol Toxicol. 2010 Mar;106(3):256-62
references: 20102365
references: Am J Med. 1972 May;52(5):633-52
references: 4337477
references: Hypertension. 2009 Feb;53(2):344-50
references: 19075095
references: Eur J Pharm Biopharm. 2010 Sep;76(1):83-94
references: 20554023
references: J Hypertens. 1998 Jun;16(6):853-62
references: 9663926
references: Can J Biochem Physiol. 1960 Jan;38:43-50
references: 13851331
references: Pharmacol Ther. 2012 Jul;135(1):1-17
references: 22475446
references: Endocr Rev. 1980 Fall;1(4):365-91
references: 6788544
references: Hypertens Res. 2006 Jul;29(7):505-13
references: 17044663